Mitral valve leaflet stiffness predicts residual mitral regurgitation after transcatheter edge-to-edge mitral valve repair. 2023

Sho Hashimoto, and Michiyo Yamano, and Tetsuhiro Yamano, and Kan Zen, and Yuki Matsubara, and Kazuaki Takamatsu, and Masaki Yashige, and Takeshi Nakamura, and Hirokazu Shiraishi, and Satoaki Matoba
Department of Cardiovascular Medicine, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan.

BACKGROUND Residual regurgitation after transcatheter edge-to-edge mitral valve repair (TMVR) is a predictor of poor prognosis in patients with functional mitral regurgitation (FMR). This study sought to identify the mitral valve (MV) parameters measured by three-dimensional transesophageal echocardiography (3D-TEE) and MV leaflet features that predict residual mitral regurgitation (MR) after TMVR in patients with FMR. METHODS Consecutive patients with FMR who underwent TMVR were classified into two groups based on the degree of residual MR just after TMVR: < 2+ in the optimal MR reduction group and ≥ 2+ in the suboptimal MR reduction group. The two groups were compared with respect to 3D-TEE parameters and the MV leaflet features, including the following parameters: stiffness, defined as a leaflet that remains at a fixed angle even during diastole, and thickness, measured in both clear and rough zones. RESULTS Thirty-four of 46 patients (74%) were classified as the optimal MR reduction group. Multivariable analysis showed that anterior mitral leaflet + posterior mitral leaflet length/anteroposterior annulus diameter (p = .044) and MV leaflet stiffness (p = .007) were independent predictors of residual MR. CONCLUSIONS MV leaflet stiffness and the ratio of MV leaflet lengths to the annulus diameter may be good predictors of residual MR after TMVR in patients with FMR.

UI MeSH Term Description Entries
D008943 Mitral Valve The valve between the left atrium and left ventricle of the heart. Bicuspid Valve,Bicuspid Valves,Mitral Valves,Valve, Bicuspid,Valve, Mitral,Valves, Bicuspid,Valves, Mitral
D008944 Mitral Valve Insufficiency Backflow of blood from the LEFT VENTRICLE into the LEFT ATRIUM due to imperfect closure of the MITRAL VALVE. This can lead to mitral valve regurgitation. Mitral Incompetence,Mitral Regurgitation,Mitral Valve Incompetence,Mitral Insufficiency,Mitral Valve Regurgitation,Incompetence, Mitral,Incompetence, Mitral Valve,Insufficiency, Mitral,Insufficiency, Mitral Valve,Regurgitation, Mitral,Regurgitation, Mitral Valve,Valve Incompetence, Mitral,Valve Insufficiency, Mitral,Valve Regurgitation, Mitral
D006348 Cardiac Surgical Procedures Surgery performed on the heart. Cardiac Surgical Procedure,Heart Surgical Procedure,Heart Surgical Procedures,Procedure, Cardiac Surgical,Procedure, Heart Surgical,Procedures, Cardiac Surgical,Procedures, Heart Surgical,Surgical Procedure, Cardiac,Surgical Procedure, Heart,Surgical Procedures, Cardiac,Surgical Procedures, Heart
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D016896 Treatment Outcome Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series. Rehabilitation Outcome,Treatment Effectiveness,Clinical Effectiveness,Clinical Efficacy,Patient-Relevant Outcome,Treatment Efficacy,Effectiveness, Clinical,Effectiveness, Treatment,Efficacy, Clinical,Efficacy, Treatment,Outcome, Patient-Relevant,Outcome, Rehabilitation,Outcome, Treatment,Outcomes, Patient-Relevant,Patient Relevant Outcome,Patient-Relevant Outcomes
D017548 Echocardiography, Transesophageal Ultrasonic recording of the size, motion, and composition of the heart and surrounding tissues using a transducer placed in the esophagus. Transesophageal Echocardiography
D019560 Echocardiography, Three-Dimensional Echocardiography amplified by the addition of depth to the conventional two-dimensional ECHOCARDIOGRAPHY visualizing only the length and width of the heart. Three-dimensional ultrasound imaging was first described in 1961 but its application to echocardiography did not take place until 1974. (Mayo Clin Proc 1993;68:221-40) 3-D Echocardiography,3D Echocardiography,Echocardiography, 3-D,Echocardiography, 3D,Three-Dimensional Echocardiography,3 D Echocardiography,3-D Echocardiographies,3D Echocardiographies,Echocardiographies, 3-D,Echocardiographies, 3D,Echocardiographies, Three-Dimensional,Echocardiography, 3 D,Echocardiography, Three Dimensional,Three Dimensional Echocardiography,Three-Dimensional Echocardiographies
D019918 Heart Valve Prosthesis Implantation Surgical insertion of synthetic material to repair injured or diseased heart valves. Implantation, Heart Valve Prosthesis

Related Publications

Sho Hashimoto, and Michiyo Yamano, and Tetsuhiro Yamano, and Kan Zen, and Yuki Matsubara, and Kazuaki Takamatsu, and Masaki Yashige, and Takeshi Nakamura, and Hirokazu Shiraishi, and Satoaki Matoba
June 2021, Journal of cardiac surgery,
Sho Hashimoto, and Michiyo Yamano, and Tetsuhiro Yamano, and Kan Zen, and Yuki Matsubara, and Kazuaki Takamatsu, and Masaki Yashige, and Takeshi Nakamura, and Hirokazu Shiraishi, and Satoaki Matoba
May 2023, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions,
Sho Hashimoto, and Michiyo Yamano, and Tetsuhiro Yamano, and Kan Zen, and Yuki Matsubara, and Kazuaki Takamatsu, and Masaki Yashige, and Takeshi Nakamura, and Hirokazu Shiraishi, and Satoaki Matoba
December 2023, JTCVS open,
Sho Hashimoto, and Michiyo Yamano, and Tetsuhiro Yamano, and Kan Zen, and Yuki Matsubara, and Kazuaki Takamatsu, and Masaki Yashige, and Takeshi Nakamura, and Hirokazu Shiraishi, and Satoaki Matoba
October 2019, Interventional cardiology clinics,
Sho Hashimoto, and Michiyo Yamano, and Tetsuhiro Yamano, and Kan Zen, and Yuki Matsubara, and Kazuaki Takamatsu, and Masaki Yashige, and Takeshi Nakamura, and Hirokazu Shiraishi, and Satoaki Matoba
December 2023, JTCVS open,
Sho Hashimoto, and Michiyo Yamano, and Tetsuhiro Yamano, and Kan Zen, and Yuki Matsubara, and Kazuaki Takamatsu, and Masaki Yashige, and Takeshi Nakamura, and Hirokazu Shiraishi, and Satoaki Matoba
January 2021, JACC. Case reports,
Sho Hashimoto, and Michiyo Yamano, and Tetsuhiro Yamano, and Kan Zen, and Yuki Matsubara, and Kazuaki Takamatsu, and Masaki Yashige, and Takeshi Nakamura, and Hirokazu Shiraishi, and Satoaki Matoba
December 2022, Journal of cardiology,
Sho Hashimoto, and Michiyo Yamano, and Tetsuhiro Yamano, and Kan Zen, and Yuki Matsubara, and Kazuaki Takamatsu, and Masaki Yashige, and Takeshi Nakamura, and Hirokazu Shiraishi, and Satoaki Matoba
October 2021, JACC. Cardiovascular interventions,
Sho Hashimoto, and Michiyo Yamano, and Tetsuhiro Yamano, and Kan Zen, and Yuki Matsubara, and Kazuaki Takamatsu, and Masaki Yashige, and Takeshi Nakamura, and Hirokazu Shiraishi, and Satoaki Matoba
March 2024, The American journal of cardiology,
Sho Hashimoto, and Michiyo Yamano, and Tetsuhiro Yamano, and Kan Zen, and Yuki Matsubara, and Kazuaki Takamatsu, and Masaki Yashige, and Takeshi Nakamura, and Hirokazu Shiraishi, and Satoaki Matoba
June 2021, JACC. Cardiovascular interventions,
Copied contents to your clipboard!